Citigroup’s Genprex GNPX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-93
Closed -$3.69K 5942
2026
Q1
$3.69K Buy
+93
New +$4.43K ﹤0.01% 5323
2025
Q4
Sell
-6
Closed -$844 5835
2025
Q3
$1.03K Sell
6
-5
-45% -$1.26K ﹤0.01% 5620
2025
Q2
$2.87K Buy
+11
New +$3.36K ﹤0.01% 5332
2022
Q2
Hold
0
-$4K 6388
2022
Q1
Hold
0
5887
2021
Q3
Hold
0
-$3K 5988
2021
Q2
Hold
0
5917
2021
Q1
Hold
0
5534
2020
Q4
Hold
0
6558
2020
Q3
Hold
0
7013
2020
Q2
Hold
0
6952
2020
Q1
Hold
0
7498

Other funds holding GNPX

Citigroup's GNPX Position: Q2 2026 in Review

Citigroup sold out of Genprex (GNPX) in Q2 2026, closing a stake of 93 shares — an estimated $3.69K sold.

Citigroup first reported a position in GNPX in Q2 2025 and held it in 3 quarters. The position peaked at $3.69K in Q1 2026. 11 funds tracked by Wall St. Rank hold GNPX as of Q2 2026.

  • Citigroup reported no remaining Genprex position as of Q2 2026 after selling out during the quarter.
  • Citigroup sold 93 Genprex shares in Q2 2026, an estimated $3.69K.
  • Citigroup first reported a position in Genprex in Q2 2025 and held it in 3 quarters.
  • Citigroup's Genprex position peaked at $3.69K in Q1 2026.
  • 11 funds tracked by Wall St. Rank held Genprex as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.